By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Hologic announced after the close of the market on Thursday that it has received regulatory approval in the US of its automated system for use with the company's human papillomavirus test.

The approval from the US Food and Drug Administration is for the Cervista HTA high-throughput automation system to be used with Hologic's Cervista HPV HR test, which was approved by the agency in 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.